Biofortuna
PrivateLast Round
VC Round
Aug 15, 2017
Company Overview
Biofortuna operates in Healthcare & Life Sciences and is based in Deeside. Its latest recorded funding round was a VC Round in August 2017.
Biofortuna is a life sciences company that provides contract development, manufacturing, and laboratory services for diagnostic and biotechnology sectors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biofortuna Comparables
Compare Biofortuna with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| IVD Research, Inc. | 79% | |
| Shandong Oriental Ocean Sci-Tech Co Ltd | 78% | |
| Lyophilization Technology, Inc. | 77% |
For institutional investors. Book with your work email.
Biofortuna Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Aug 15, 2017 | ||||
| VC Round | Jan 29, 2015 | ||||
| VC Round | Aug 20, 2013 | ||||
| VC Round | Apr 11, 2012 | ||||
| VC Round | May 25, 2010 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Biofortuna Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Merseyside Special Investment Fund | VC Round |
| Foresight Group LLP | VC Round |
| Mercia Asset Management | VC Round |
| Catapult Ventures | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 11, 2026
Monthly visitors increased 124% MoM, reaching 2.5K.
- Aug 15, 2017
$2.1M round led by Foresight VCTs.
For institutional investors. Book with your work email.
Biofortuna Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Biofortuna's valuation, stock price, and market status.
Is Biofortuna a public or private company?
Biofortuna is a private company.
What is the current stock price of Biofortuna?
Biofortuna is a private company, so its shares have no public market price. Caplight tracks Biofortuna's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Biofortuna worth (valuation)?
Valuation information for Biofortuna is not publicly available.
Can I buy Biofortuna stock?
Biofortuna shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Biofortuna's last funding round?
Biofortuna's most recent funding round was VC Round on August 15, 2017.
Who are the main investors in Biofortuna?
Key investors in Biofortuna include Foresight Group LLP.
Will Biofortuna IPO soon?
No public IPO plans have been announced for Biofortuna.
How can I track Biofortuna secondary market activity?
Caplight tracks bids, offers, and trades in Biofortuna's shares on secondary markets.